Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page
- Check6 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page footer; no study details or user-facing content were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check20 days agoChange DetectedThe funding-status notice banner about potential data staleness due to government funding lapses has been removed from the page. This administrative banner previously warned that information on this site may not be up to date.SummaryDifference0.3%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedNo significant changes were detected in the Study Details page for NCT03854474. The content and layout appear unchanged aside from routine metadata such as the last update timestamp.SummaryDifference0.3%

- Check63 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check70 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new release version.SummaryDifference0.0%

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.